Results 111 to 120 of about 791,952 (357)

Helical tomotherapy experience in breast cancer adjuvant radiotherapy and acute toxicity results

, 2022
Gonca Altınışık İnan, İpek Pınar Aral, Aliye Arslan, Tuğba Ozkader Celik, Hüseyin Furkan Öztürk, Süheyla Aytaç Arslan, Yılmaz Tezcan   +6 more
openalex   +2 more sources

Breast Deformations Measured With Cone Beam Computed Tomography During Adjuvant Radiotherapy for Breast Cancer [PDF]

, 2021
Lisa Perron-Gagnon, Louis Archambault, Nicolas Varfalvy, O. Piron, Valérie Théberge   +4 more
openalex   +1 more source

Low YTHDC1 Expression Upregulates FSCN1 to Promote Nuclear F‐Actin Formation and Facilitate Double‐strand DNA Breaks Repair in TMZ‐Resistant Glioblastoma

Advanced Science, EarlyView.
This study revealed that low expression of YTHDC1 in TMZ‐resistant GBM cells leads to increased FSCN1 expression, which is suppressed by m6A modification. FSCN1 activates the CDC42/N‐WASP/Arp2/3 axis in the cell nucleus by recruiting the guanine nucleotide exchange factor (GEF) family member FGD1, thereby promoting F‐actin polymerization in the nucleus.
Minglong Yang, Wanxiang Niu, Yuanfei Wang, Peng Chen, Maolin Mu, Xiaoming Zhang, Ben Xu, Shanshan Hu, Chaoshi Niu, Pengfei Wu   +9 more
wiley   +1 more source

Outcomes of definitive radiotherapy vs. laryngectomy followed by adjuvant radiotherapy in patients with locally advanced laryngeal squamous cell carcinoma: real-world experience in a referral cancer center

Radiation Oncology
Background Laryngeal cancer is a common head and neck cancer. Surgical treatment can impair patients’ voice and swallowing function, making definitive radiotherapy a viable alternative for locally advanced cases.
Ali Kazemian, Ebrahim Esmati, Reza Ghalehtaki, Borna Farazmand, Nima Mousavi-Darzikolaee, Reyhaneh Bayani, Mahdieh Razmkhah, Maryam Taherioun, Niloufar Saeedi, Farrokh Heidari, Kaveh Zakeri   +10 more
doaj   +1 more source

Adjuvant Carboplatin and Paclitaxel Chemotherapy Followed by Radiotherapy in High-Risk Endometrial Cancer: A Retrospective Analysis

Journal of Global Oncology, 2018
Purpose: The best adjuvant treatment in high-risk endometrial cancer remains unclear. Although adjuvant chemotherapy seems to improve overall survival (OS) in locally advanced disease, the role of adding radiotherapy is not certain.
Renata Rodrigues da Cunha Colombo Bonadio, Renata Gondim Meira Velame Azevedo, Guilherme Harada, Samantha Cabral Severino da Costa, Vanessa Costa Miranda, Daniela de Freitas, Elias Abdo Filho, Patricia Alves de Oliveira Ferreira, Flavia Gabrielli, Maria Del Pilar Estevez Diz   +9 more
doaj   +1 more source

Utilizing propensity score matching methodology to assess the impact of adjuvant radiotherapy on the prognosis of men diagnosed with breast cancer [PDF]

, 2023
Jing Meng, Qi Wu, Jianlin Wang, Aimei Zhao, Huiwen Ren, Zhiqiang Sun, Judong Luo   +6 more
openalex   +1 more source

Neo-adjuvant radiotherapy in rectal cancer

World Journal of Gastroenterology, 2013
In rectal cancer treatment, attention has focused on the local primary tumour and the regional tumour cell deposits to diminish the risk of a loco-regional recurrence. Several large randomized trials have also shown that combinations of surgery, radiotherapy and chemotherapy have markedly reduced the risk of a loco-regional recurrence, but this has not
openaire   +2 more sources

Keloid treatment: what about adjuvant radiotherapy?

Clinical, cosmetic and investigational dermatology, 2019
Background: Keloids are debilitating fibrous skin proliferations with a high recurrence rate after surgical treatment. Postoperative radiotherapy (PORT) is a well-tolerated adjuvant treatment to reduce the risk of recurrence, but the optimal regimen for this combined treatment remains unknown.
Petrou, Ilias, Jugun, Kheeldass, Ruegg, Eva, Zilli, Thomas, Modarressi Ghavami, Seyed Ali, Pittet Cuenod, Brigitte Maud   +5 more
openaire   +5 more sources

A20 Facilitates Oxaliplatin Sensitivity in Colorectal Cancer Through Monoubiquitylation of IKK‐β

Advanced Science, EarlyView.
This study demonstrates that the expression of A20, a ubiquitin‐editing enzyme, is positively correlated with oxaliplatin sensitivity in colorectal cancer (CRC). Mechanistically, A20 enhances oxaliplatin sensitivity by inhibiting NF‐κB nuclear translocation through monoubiquitination of IKK‐β.
Fan Luo, Ting Yang, Jiaxin Cao, Qun Chen, Zhenhai Lu, Feiteng Lu, Chaozhuo Lin, Zengfei Xia, Yuanzhong Yang, Peng Li, Wenjuan Ma, Min Luo, Rongxin Zhang   +12 more
wiley   +1 more source

The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma [PDF]

, 2019
Geumju Park, Si Yeol Song, Jin‐Hee Ahn, Wanlim Kim, Jong‐Seok Lee, Seong‐Yun Jeong, Jae Won Park, Eun Kyung Choi, Wonsik Choi, In‐Hye Jung   +9 more
openalex   +1 more source